CEFOTAXIME SODIUM
MENINGOCOCCAL MENINGITIS·+79
WEST-WARD,INC.
Indication
Proteus peritonitis
*Proteus* peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Proteus*, most frequently *Proteus mirabilis* or *Proteus vulgaris*. Read more about Proteus peritonitis
10 drugs 8 manufacturers
Drugs that treat it
Common Proteus peritonitis therapies.
CLAFORAN (cefotaxime sodium)
MENINGOCOCCAL MENINGITIS·+79
Sanofi-Aventis U.S.
CLAFORAN (cefotaxime sodium)
MENINGOCOCCAL MENINGITIS·+79
HOSPIRA
CEFOTAXIME SODIUM
MENINGOCOCCAL MENINGITIS·+79
CURA PHARM
CEFOTAXIME (cefotaxime sodium)
MENINGOCOCCAL MENINGITIS·+79
WEST-WARD,INC.
CLAFORAN (cefotaxime sodium)
MENINGOCOCCAL MENINGITIS·+79
SANOFI-AVENTIS/
CLAFORAN (cefotaxime sodium)
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+79
Hospira
CLAFORAN (cefotaxime sodium)
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+79
Hospira
CEFOTAXIME (cefotaxime sodium)
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+79
STERIMAX INC.
Filter & compare in the drug finder →Opens the drug finder with Proteus peritonitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Proteus* peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Proteus*, most frequently *Proteus mirabilis* or *Proteus vulgaris*.
It typically affects patients experiencing secondary peritonitis due to gastrointestinal tract disruption—such as visceral perforation, ischemic bowel necrosis, or surgical contamination—as well as individuals undergoing peritoneal dialysis via transluminal migration or catheter-related contamination.
Pathophysiologically, the organism's motility, endotoxin release, and innate inflammatory activation lead to purulent exudation, severe diffuse abdominal pain, guarding, cloudy peritoneal dialysate, and a high risk of bacteremia and septic shock.
- wikimedia.org
*Proteus* peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Proteus*, most frequently *Proteus mirabilis* or *Proteus vulgaris*
- nih.gov
*Proteus* peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Proteus*, most frequently *Proteus mirabilis* or *Proteus vulgaris* It typically affects patients experiencing secondary peritonitis due to gastrointestinal tract disruption—such as visceral perforation, ischemic bowel necrosis, or surgical contamination—as well as individuals undergoing peritoneal dialysis via transluminal migration or cathete...
- fda.gov
*Proteus* peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Proteus*, most frequently *Proteus mirabilis* or *Proteus vulgaris*
- nih.gov
It typically affects patients experiencing secondary peritonitis due to gastrointestinal tract disruption—such as visceral perforation, ischemic bowel necrosis, or surgical contamination—as well as individuals undergoing peritoneal dialysis via transluminal migration or catheter-related contamination Pathophysiologically, the organism's motility, endotoxin release, and innate inflammatory activation lead to purulent exudation, severe diffuse abdominal pain, guarding, cloudy peritoneal dialysate,...
- nih.gov
It typically affects patients experiencing secondary peritonitis due to gastrointestinal tract disruption—such as visceral perforation, ischemic bowel necrosis, or surgical contamination—as well as individuals undergoing peritoneal dialysis via transluminal migration or catheter-related contamination Pathophysiologically, the organism's motility, endotoxin release, and innate inflammatory activation lead to purulent exudation, severe diffuse abdominal pain, guarding, cloudy peritoneal dialysate,...
- nih.gov
It typically affects patients experiencing secondary peritonitis due to gastrointestinal tract disruption—such as visceral perforation, ischemic bowel necrosis, or surgical contamination—as well as individuals undergoing peritoneal dialysis via transluminal migration or catheter-related contamination
- fda.gov
Pathophysiologically, the organism's motility, endotoxin release, and innate inflammatory activation lead to purulent exudation, severe diffuse abdominal pain, guarding, cloudy peritoneal dialysate, and a high risk of bacteremia and septic shock
Personalize your experience
Follow Proteus peritonitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.